Trial Profile
The Efficacy and Safety of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumors: a Prospective Single-arm Clinical Study
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 01 Mar 2023
Price :
$35
*
At a glance
- Drugs Catequentinib (Primary) ; Antineoplastics
- Indications Fibroma
- Focus Therapeutic Use
- 27 Feb 2023 Status changed from not yet recruiting to recruiting.
- 12 Aug 2022 New trial record